医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Agilent Named One of Singapore’s Best Employers

2021年04月14日 AM09:00
このエントリーをはてなブックマークに追加


 

SINGAPORE

Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out of eight in the Drugs & Biotechnology category.

“This year, Agilent Singapore is among the top 100 positions compared to our 108th ranking last year, so we’ve continued to excel—even during COVID,” said Woai-Sheng Chow, Agilent Singapore Vice President and General Manager, Global Instrument Manufacturing. “We are enormously proud of our employees.”

Rankings were determined on the results of an extensive independent survey conducted by the newspaper and Statista, a global research firm. The survey included more than 9,000 employees working at companies with more than 200 people. Employees were consulted anonymously through several online panels and through The Straits Times website. In total, more than 200,000 recommendations were evaluated, based on two distinct criteria. The first was a “direct recommendation,” an employee’s willingness to recommend their company to friends and family. The second was an “indirect recommendation,” an employee’s evaluation of other employers in their respective industries.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers’ most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom.

Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210413006097/en/

CONTACT

Media Contact

Tom Beermann

Agilent Technologies

+1.408.553.2914

tom.beermann@agilent.com

Media Contact

Soo-Chun Tan

Agilent Technologies – Singapore

+65 6276 2622

soo-chun.tan@agilent.com

同じカテゴリーの記事 

  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024